The MTL Cannabis Corp. (CSE:MTLC) share price has softened a substantial 27% over the previous 30 days, handing back much of the gains the stock has made lately. Looking back over the past twelve months the stock has been a solid performer regardless, with a gain of 25%.
Although its price has dipped substantially, there still wouldn’t be many who think MTL Cannabis’ price-to-sales (or “P/S”) ratio of 0.5x is worth a mention when the median P/S in Canada’s Pharmaceuticals industry is similar at about 0.8x. Although, it’s not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
View our latest analysis for MTL Cannabis
What Does MTL Cannabis’ P/S Mean For Shareholders?
Revenue has risen firmly for MTL Cannabis recently, which is pleasing to see. One possibility is that the P/S is…
